This document describes the process of lymphopoiesis, or lymphocyte development. It discusses the development of lymphocytes from stem cells in primary lymphoid organs like the bone marrow and thymus, then migration to secondary lymphoid tissues where further differentiation occurs upon antigen exposure. Key cell types in lymphocyte development include lymphoblasts, prolymphocytes, small and large lymphocytes, and their defining characteristics. The roles of the microenvironment and cytokines in lymphopoiesis are also summarized.
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
Hemo: Referring to blood cells
Poiesis: “The development or production of”
The word Hemopoiesis refers to the production & development of all the blood cells
This presentation is focused on diagnostic utility of Red blood cell indices which will be very useful for undergraduate and postgraduate of medical field.
Hemo: Referring to blood cells
Poiesis: “The development or production of”
The word Hemopoiesis refers to the production & development of all the blood cells
This presentation is focused on diagnostic utility of Red blood cell indices which will be very useful for undergraduate and postgraduate of medical field.
It is in these organs where the cells of the immune system do their actual job of fighting off germs and foreign substances.
Bone marrow. Bone marrow is a sponge-like tissue found inside the bones. ...
Thymus. The thymus is located behind the breastbone above the heart. ...
Lymph nodes. ...
Spleen. ...
Tonsils. ...
Mucous membranes.
Non hodgkins lymphomas are of two cell types
T-cells
And B-cells
T-cells constitute only 10% of all Non-hodgkins lymphomas.
T cell lymphomas
Basic introduction of the T -cells-development , maturation and functions.
Cell of origin of various nodal and extranodal lymphomas
WHO classification revised 4th edition
Precursor lymphomas-
T-cell prolymphoblastic leukemia/lymphoma
Nodal lymphomas - Angioimmunoblastic lymphoma
Anaplastic lymphoma (ALK+&ALK-)
Peripheral T cell lymphoma - NOS
Extranodal lymphomas-
EN-Nk T-cell lymphoma nasal type
Intestinal lymphomas
EATL
METL
Hepatosplenic lymphoma
Leukemic lymphomas
Adult T cell leukemia
T-cell prolymphocytic leukemia
T cell large granular lymphocytic leukemia
Cutaneous lymphomas
Mycosis fungoides
Sezary syndrome
Summary:
CD8+/CD4- in Extranodal lymphomas: Hepatosplenic lymphomas, MEITL, T-LGL
CD4+/CD8- with diffuse CD30+ is ALCL .
CD4+/CD8- with TFH and TF dendritic markers + is AITL.
CD4+/CD8- with HTLV exposure is ATLL.
CD4+/CD8- with loss of CD7 with cutaneous manifestations+ epidermotropism+spongiosis is Mycosis fungoides.
Waste basket category is PTCL-NOS
CD4+CD8-CD10-PD1- with lymphocytosis is T-PLL
References
Immunology is the study of the immune system and is a very important branch of the medical and biological sciences. The immune system protects us from infection through
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
1. Lymphopoiesis
LYMPHOBLAST
• Description:
Firstmorphologically recognizable cell oflymphocytic lineage, roundin shape. Under
normal conditionsit exists in secondarylymphoid folliculi.
• Size:
15-25µm.
• Cytoplasm:
Homogenous,basophilic,with the colora little bit more intensive at the margins; no
granules.
• Nucleus:
Roundorslightly oval; it has a fine dispersed chromatin whichis coarser thanin the
myeloblast. High nucleocytoplasmatic ratio (5:1 to 7:1).
• Nucleoli:
Only oneor twoblue colored nucleoli are present.
PROLYMPHOCYT E
• Description:
The secondmorphologically recognizable cell of the lymphocytic lineage, smaller than
lymphoblast but larger than mature lymphocyte.
Prolymphocytecansometimes be foundin the peripheral blood.
• Size:12-18µm.
• Cytoplasm:
Blue andrelatively more abundantthan in the lymphoblast, nogranules.
• Nucleus:
Coarserchromatinic structure,but,unlike the lymphocyte, chromatin is notclumped but
has a granular appearance.
• Nucleoli:
Poorlyvisible.
LYMPHOCYTE
• The cell that is normally foundinthe bonemarrow,lymphoid organsand in blood,
butin variouspercentages.
• Twotypes of lymphocytes canbe distinguished: small and large ones.
SMALLLYMPHOCYTE
• Description:
Small lymphocytes are the major partof lymphocytes in the blood.The cell has a large
roundishand regular nucleus.
• Size:
9µm.
• Cytoplasm:
Scantycytoplasm is often barely visible and quite often seen only at the nuclear
periphery. It may form a fine blue line aroundthe nucleusorhave the appearanceof a
pointed hat. The cytoplasm does notcontain granules.It is distinctly basophilic witha high
nucleocytoplasmic ratio (about9:1).
• Nucleus:
Eccentricallylocated, roundor oval, oftenwith an indentation in one place; chromatin is
heavily clumped,forming compactlumpyaccumulationswithout sharpdemarcations.
• Nucleoli:
Not visible.
• LARGE LYMPHOCYT E
• Description:
Largelymphocytes are the minor part oflymphocytes in the bloodstream. The cell has a
large roundishandregular nucleus.
• Size:
10-15µm.
• Cytoplasm:
2. Fairly abundantand sky-blue color;there may be upto 10azurophilic granules. They are
approximately 0.5µ in diameter.
• Nucleus:
Slightly eccentric located, roundoroval, sometimes slightly indented; chromatin is
arranged in compactblocks,separated by lighter zoneswithout sharpdemarcation, often
there are unclearly divided clumps.
• Nucleoli:
Not visible.
Lymphopoiesis
• Primary lymphoid organs(PLO)–BMand thymus
• Secondarylymphoid tissues (SLT)-LN,spleen, tonsils, peyer’s patches
• PLOsupplies the SLT withpartially differentiated lymphocytes
• Lymphopoiesis in PLOis continuousandantigen independent in SLT they become
immunocompetent.
• Immunocompetentcells develop along the defined pathways ofL differentiation
eg.BM – multipotential thymocytic progenitor(pro/pre-Tcell) – T cell
in BM – Bcell
NK cells fromtotipotent stem cells
• microenvironment – critical to its development andfunction.Effectsoflymphocyte
interaction with macrophages,fibroblasts, dendritic cells, endothelial cells.
• Soluble factors– cytokinesand interleukins (IL)
• (CAMs) celladhesion molecules – ligands orcoreceptorsfor surfaceproteinsand
facilitate adhesion to other cells
enables Lymphocytic cells to migrate, home andrecirculate…
Bone marrowlymphopoeisis
• Begins withtotipotent hematopoieticstemcells.
• Stem cells are foundin BM andcapable of self-replication. Once start to
differentiate becomes committed to a specific cell type
B cells
• Differentiation ofB pathwaysmay proceed in bonemarrow . Some precursorcell
may also migrate to peripheral organslike spleen
• Pro-B(progenitor)cell-earliest , CD19andTdT withoutIg
• Pre-B(precursor)cell–gene Ig rearrangement
dependent on IL-7– Heavy Chain Igexpression and upregulated by c-kit
initially they are large , rapidly dividing, with convolutednucleusandfollowed by a small ,
slowly dividing pre b cells. (infants,px withaplastic anemia orafter marrow transplantation,
LN after Agstimulation) – mononuclear,10-20um,largenucleus,homogenous chromatin,
cleft nucleus,deep blue scantycytoplasm w/ogranules and vacuoles
• Pre Bcell retain – HLA DRAg,CD19,some TdT
-rearrangement ofIg genes- m-heavy chains(HC) inpreB cells are evident
• Immature B cells – absence ofCD10 andTdT, 1st
appearance ofsurfaceIg(SIg),
intracytoplasmic HCof IgMtype,
{ CD20,CD22,CD40 appear} CD19isretained until plasma cell diff.
• Mature B cells- Light Chain(LC) aresynthesized joinedwith HCinserted in the
plasma membrane
LC–either lambda l, kappa k chains
but notboth
only mature B cells bind Ag– canbe activated andmultiply
Migrate to 2ndarylymphoid tissue (SLT)
where antigen-dependent phase ofdevelopment occurs
10%are precursors
90%are resting mature Bcells
Naturalkillercells
• Bone marrow-primary developmental site and also thymus
• Large granularlymphocytes
• + for CD2,CD11b,CD16,CD56antigensandnonadherent and nonphagocytotic
3. • CD16 andCD 56are the most aggressive
• Controlled by IL-2 cytokine
Thymic Lymphopoiesis
• Prothymocyte(pro-Tcell) originates from the CFU-Linthe marrow.
Agpresent like – c-kit, pan-T cell lineages CD2
andCD7, HLA-DRandcytoplasmicCD3(hallmark of T cell lineage)
Pro-Tcell-migrates to thymus,reacts with thymic environment (eg.Dendritic epithelial
cells , macrophages,intedigitating dendritic cells). Thymosinalso play onits differentiation
• Thymus
medulla ( central region),cortex(peripheral region ) enclosedwithin a capsule
cortex– large lymphocytes,rapidly dividing in absence ofantigens
medulla – immunocompetentcells
3 distinct intrathymic differentiation
1. subcapsular
2. common(cortical)
3. mature (medullary)
• Definitive marker for T cells are T cell antigen receptor (TCR)signallingcomplex
(TCR/CD3)
• TCRgene rearrangement
• CD4and CD8are acquiredin the cortexand2 subsets oflymphocytes eventually
develops
1. helper cells – CD4
2. suppressororcytotoxic cells – CD8
5% ofthymocytes leave the thymusand most migrate to SLT
• MHCmajor histocompatibility complex restrictions – important in Tcell
development
• T cells are programmed to recognizeAgonly whenit is linked to certain MHC
molecules on target cell surface(MHCrestrictions) eg. Helper T cell – MHCclass II
and cytotoxic cells are class I MHCrestricted
Secondarylymphoidtissue lymphopoiesis
• Germinal centersinside lymphoid follicles in the spleen ,LN , peyer’s patches , and
other mucosalassociated lymphoid tisssue (MALT)
• Newly formed lymphocytes are released by the secondarylymphoid tissue –
antibody response
Spleen
• Red pulp
• White pulp
• Marginalzone
• T cellsmove from marginalzone of the white pulp to PALS – migrate from
spleenfor only 5-6hours
• B cellsmove from marginalzone toPALS mixwith T cellsthento germinal
centersof W.pulpthen tovenous sinuses of the red pulp– 24hrs
Lymphnode
• Enclosedin acapsule withcontinuous endotheliallining.
• Afferent lymphaticvesselsthat penetratesthe capsule that carrieslymph
loadedwith Aginto the node to be filtered.Lymphentersthe subcapsularsinus
where it comesincontact withlymphocyte andmacrophages.The subcapsular
sinuses communicate withmedullarysinusesandemptyintoefferent
lymphatics
• Divided intocortexandmedulla
• Cortexcontainsprimaryandsecondaryfollicles(mantlezones)
• Medulla – cord like aggregatesoflymphocytesandplasmacells
2 routes of lymphocyte entryintoLN
1. afferent lymphatics
2. blood tru endothelialliningofpost capillaryvenules
• Thymusdependent zones- paracortex
4. • B celldependent zones-B cellsfrom germinalcentersmove tomedulla –
efferent lymphatics–viamedullarycordsin deepportion
• LymphoidfolliclesaccomplishT celldependent,antigeninducedBcell
proliferationanddifferentiation.
• Germinalcentersappeartobe the site of transformationof the B cellfromsmall
to large lymphocyte andleavesgerminalcenterasanimmunoblast towardsthe
medullary cordsto become plasmacytoidlymphocytesorplasmacells
Lymphatic aggregates
• Dense accumulationsoflymphocytesfoundinloose ct throughout GIT,RT,and
Urogenitaltractsassociatedwithmucosalsurfaces
• MALT
Lymphokinetics
• The process of lymphocyte multiplication, maturation,storage,andmigration
to tissuesincludingsitesof infectionor celldamage.
• Mitosis andMultiplication–radioisotope labeling
• BM fastest turnover,thymus– 2nd
Pre B cells– 0.6% in BM, 6%amonglymphocytes,3-4daystodevelop
T cells– supplied by BM precursors
• Lifespan
definingis difficult,most have short lifespan,influence byitsenvironment
high rate of productionand turnover
• Migration
adhering,traversing,and detachment fromendothelium
Traffickingorhoming– circulationandmigrationofcellstospecific tissues
Affectedby variousmolecules/mediatorslike –
(selectins,chemokines,chemoattractantreceptors,Igsuperfamilyeg.integrin
ligands,integrins)
HEV – high endothelialvenules
• Lymphocytesinteractwithendothelialcells, migrate intolymphoidornon
lymphoid
• Lymphocytessearchforantigens
• Once in the tissuesL move amongother cells( skin ,LN,spleen,lung, or
intestinalmucosa)
Function
• Major functionof lymphocytes
1. antigenrecognition
2. generationofappropriate immune response
B cells
function
• Diffrentiate intoplasmacellsthat secretesglycoproteinIgs(humoralimmunity)
• Producesvarietyof Igs
• Ig – removaland degradationof foreignbody (complement ,neutralization,)
• Produce cytokines–both B&T cells
• Mitogens– stimulatestransformationandmitosis
• Productionof plasmacellsandmemorycells
• Memorycells
T cell
function
• Effectorandregulatory function
• EffectorTcell –cellmediatedimmunitylike defense against intracellular
bacteriaorfungalinfections,cytolysisofvirusinfectedcells,allograft
rejections,GvHrxn, Tumorimmunity
• Subsetsof T cellsystem
1. Helper/InducerT lympocyte (TH) –CD4
2. DelayedhypersensitivityT L(DHTLor TD)
3. Cytotoxic TL(CTL) –CD4&CD8
4. Suppressor TL(TS)-CD8
5. Helper/ inducerT cell
• Induce other T celland B celltoproduce Antibody
• Release interleukins
• Physicalcontact –MHCclassII withspecialmarkerCD4
• IL2(CD25) – growth factorproliferationofactivatedT cellsdependent onIL1
releasedby macrophages
Delatedhypersensitivity
T lymphocytes
• Producedchemotactic lymphokineswhichconfine oractivate macrophages
(MIF) – migrationinhibitionfactor-IL4-membrane alterationscausingclumpingand
immobilizationofcells
(MAF)-macrophage activatingfactor-IF-g–antiviralactivity,inhibitionoftumor
growth, enhancement ofNKcellactivityandantibodydependent cell mediated
cytolysis(ADCC),alterationofcellmembranes,macrophage activation
• Recruit uncommittedlymphocytes
• Allergic reaction
Cytotoxic
t lymphocytes
• Both CD4 andCD8
• Induced toperform cytotoxic function
• Recognizedonly MHC classI
• Ability torecycle
Suppressor
T lymphocytes
• Regulate bothcellmediatedandhumoralimmunity
• CD8 as surface marker
• Inducer,effector,transducer
Large granularlymphocytes
• Large cellswithpale blue cytoplasm,lowNCratioandcytoplasmic azurophilic
granules
• 3 classes
1. naturalkillercells-NKcells
2. killercells-Kcells
3. lymphokine activatedkillercells-LAK
Naturalkillercells
• Function
1. recognitionandlysisof certaintumorcellsandvirus infectedcellswithout MHC
restriction
2. resistance tocertainbacterial,fungalandparasitic agents
3. immune regulation
4. regulationof hemopoiesis
5. naturalresistance toallogenic grafts
• Theyrecognizedtargetsnon-immunologically
• EnhancedbyIFN-g,IL2
• Target malignant cells,virusinfectedcells,fetalcells,subpopulationsof
thymuscells,BM cells,macrophages
• React withsyngeneic,allogeneic,xenogeneic
• Found in blood and spleen
Killercells
• Cytotoxic lymphocytes
• Antibodydependent cellmediatedcytolysis(ADCC)
• High affinityforIgG Fc receptor(FcR)
• Virusinfections,tumors,autoimmune disease
Lymphokine-Activated
Killercells
• ActivateddirectlybyIL2
• Phenotypicallydifferent fromNKcells
6. • Ability tomediate lysisoffreshtumor target cellsthat are resistant toNKcell
lysis
Cytokines
• Producedby specific andnon-specific helper/inducerL,cytolytic andsuppressor
TL,activatedT andB lymphocyte
• Proteinsthat functionto moderate effectorcellnumberandfunction.
• Types– interferons,tumornecrotic factor(TNF),Igsuperfamilymembers,
chemokines,hematopoietins(GM-CSF)
Monocytes
• Monocytesoriginate inthe bone marrow afterdifferentiationinto monoblasts
and promonocytes.Macrophagesare monocytesdistributedoutside the blood,
allover the body, especially inthe liver,spleen,lymphnodes,lungs, bone
marrow,connective tissue,andserous cavities.Monocytesphagocytize
bacteriaandlargerparticles;theycontaingreat quantitiesoflipase andcan
thus degrade bacteriawithlipidic capsule,suchastuberculosisandleprotic
bacteria.Monocyteshave adominant role in immunitybecause theypresent
the ingestedantigenon theirsurface so that it canbe recognizedby
lymphocytes.
• The maturationprocessand divisionin the bone marrowlast 16 to 26 hours.
Afterleavingthe bone marrow,monocytesremaininthe bloodstreamabout 7
days,then move into tissues,where theybecome macrophages.Theycan
proliferate toasmallextent,especiallyinthe place ofinflammatoryreaction.
Today it is indisputably clearthat the monocytesinthe blood and macrophages
in the tissues are the same cellspecies.Theyare classifiedasmononuclear
phagocytes.
Developmentalstagesofmonoblasts
• MONOBLAST
• Description:
The most immature precursorwithmorphologic featuresofmonocytic lineage and
the first morphologicallyrecognizablecellofthe monocytic lineage,roundoroval
shape.
Monoblast is instructure verysimilarto the myeloblast fromwhich it cannot be
distinguishedon morphologicalgrounds alone,evenby meansof the electronic
microscope.Theycanbe differentiatedusing cytochemicalmethods.
• Size:
20 µm.
• Cytoplasm:
Blue or greyishand no granules.
• Nucleus:
Large,round or slightlyindented,andthe chromatinis veryfine and indistinct.
• Nucleoli:
1-2 nucleoli.
• PROMONOCYTE
• Description
The second recognizable cellofthe monocytic lineage,roundor ovalshape.
• Size:14-20µm
• Cytoplasm:
Bright blue and maycontaineitherfewor manyfine azurophilic peroxidase negative
granules.
• Nucleus:
Large,indentedor notched,irregularin form,and shows some protuberancesin the
cytoplasm.
• Nucleoli:
Clearlyvisible.
• MONOCYTE
• Description:
The cellis round or oval shape. Because ofameboidmovementson the edge of the
cell1,2 or more pseudopodia canbe seen.
7. Monocytesenterthe blood and migrate tothe tissues to become macrophages.Unlike
neutrophils,monocytesinthe peripheralblood retainmitochondriaandribosomes,so
theyare able to synthesizeproteins.
Monocytescanbe found in the peripheralblood of healthyadults,inthe percentage of
1-9%, and in about 9% in children.
• Size:15-30µm
• Cytoplasm:
Relatively abundant dullgrey-blue;mayhave aground-glass appearance witha
numberof evenly distributedfine azurophilic granules.
• Nucleus:
Usuallyround or kidney-shapedbut maybe markedlyindentedoreven lobulated,
withtwo or more lobes. The chromatinisarrangedin strands with lighterspacesin
between,givingaloose skin-like appearance.
It is locatedsubcentrallyormore towards the peripheryof the cell.As arule,the
concave side of the nucleusfacesthe widest part of the cell.
• Nucleoli:
Not visible.
• MACROPHAGE
• Description:
Cellswithremarkable ability ofphagocytosis.
Phagocytesare dividedintotwo groups: polymorphonuclearphagocytesand
mononuclearphagocytes.The latterare macrophages,monocytes,promonocytes,and
theirprecursors in the bone marrow.
Monocytic-macrophagocytic systemhasasignificant functioninthe organism - it
eliminatesantigens,presentsantigentolymphocytes,andsecretesthe factors
stimulatinglymphocytestoreact more powerfully.
Macrophage is acellof various shapes,round or kidney-shapednucleus,withnumerous
cytoplasmaticinclusionsandirregularsurface withalot of folds and protuberances.
• Size:10-25µm
• Cytoplasm:
Numerouscytoplasmaticinclusions.Macrophagescandifferinthe amount,
structure and locationofcytoplasmatic enzymes.
• Nucleus:
Kidney-shapedor oval.
• Nucleoli:
Absent.
###Monocytosis
• Monocytosisis the state ofexcessmonocytesinthe peripheralblood. It maybe
indicative ofvariousdisease states.Examplesofprocessesthat canincrease a
monocyte count include:
• 1.chronic inflammation
• 2.stress response
• 3.hyperadrenocorticism
• 4.immune-mediateddisease
• 5.pyogranulomatousdisease
• 6.necrosis
• 7.red cellregeneration
• 8.ViralFever
• 9.sarcoidosis
• >Ahigh count of CD14+CD16++monocytesisfound in severe infection
(sepsis) and avery low count of these cellsis found aftertherapywithimmuno-
suppressive glucocorticoids[6]
###Monocytopenia
• Monocytopenia isa formof leukopenia associatedwithadeficiencyof
monocytes.